Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.827 | 0.200 | 2 | 238246412 | missense variant | C/T | snv | 0.21 | 0.15 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.827 | 0.200 | 2 | 238246412 | missense variant | C/T | snv | 0.21 | 0.15 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.827 | 0.200 | 2 | 238246412 | missense variant | C/T | snv | 0.21 | 0.15 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.827 | 0.200 | 2 | 238246412 | missense variant | C/T | snv | 0.21 | 0.15 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.827 | 0.200 | 2 | 238246412 | missense variant | C/T | snv | 0.21 | 0.15 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.827 | 0.200 | 2 | 238246412 | missense variant | C/T | snv | 0.21 | 0.15 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.827 | 0.200 | 2 | 238246412 | missense variant | C/T | snv | 0.21 | 0.15 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.827 | 0.200 | 2 | 238246412 | missense variant | C/T | snv | 0.21 | 0.15 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.827 | 0.200 | 2 | 238246412 | missense variant | C/T | snv | 0.21 | 0.15 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.827 | 0.200 | 2 | 238246412 | missense variant | C/T | snv | 0.21 | 0.15 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
1.000 | 0.120 | 2 | 238249067 | missense variant | C/T | snv | 1.8E-03 | 8.5E-04 |
|
Nervous System Diseases; Mental Disorders; Occupational Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
1.000 | 0.040 | 2 | 238252912 | splice region variant | G/A | snv | 4.0E-06 | 7.0E-06 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
2 | 238253316 | missense variant | C/T | snv | 2.9E-02 | 3.0E-02 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
0.925 | 0.120 | 2 | 238257003 | missense variant | T/C | snv |
|
0.700 | 1.000 | 1 | 2001 | 2001 | |||||||||
|
0.925 | 0.120 | 2 | 238257003 | missense variant | T/C | snv |
|
Nervous System Diseases; Mental Disorders; Occupational Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.790 | 0.240 | 2 | 238262991 | missense variant | G/A;T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.240 | 2 | 238262991 | missense variant | G/A;T | snv | 4.0E-06 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.240 | 2 | 238262991 | missense variant | G/A;T | snv | 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.240 | 2 | 238262991 | missense variant | G/A;T | snv | 4.0E-06 |
|
Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.240 | 2 | 238262991 | missense variant | G/A;T | snv | 4.0E-06 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.240 | 2 | 238262991 | missense variant | G/A;T | snv | 4.0E-06 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.240 | 2 | 238262991 | missense variant | G/A;T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.240 | 2 | 238262991 | missense variant | G/A;T | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 2 | 238271489 | frameshift variant | G/- | delins |
|
0.700 | 0 | |||||||||||||
|
1.000 | 0.120 | 2 | 238273263 | intron variant | A/G | snv | 0.35 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 |